The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.20
Bid: 135.00
Ask: 135.60
Change: -0.80 (-0.59%)
Spread: 0.60 (0.444%)
Open: 135.00
High: 136.00
Low: 133.20
Prev. Close: 135.00
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

16 Nov 2018 07:00

RNS Number : 5500H
Kier Group PLC
16 November 2018
 

KIER GROUP PLC

AGM TRADING UPDATE

 

Kier Group plc, a leading infrastructure services, buildings and developments & housing group, announces its trading update covering the period since 20 September 2018, prior to its Annual General Meeting at 12 noon today.

 

Introduction

The Board is confident that the Group will meet its FY19 expectations, with the full-year results being weighted towards the second half of the financial year.

 

Future Proofing Kier (FPK) programme

Since its launch, the FPK programme has made good progress with respect to streamlining the business and improving cash generation.

 

As anticipated, the costs of implementing the FPK programme in the first half of the financial year are forecast to exceed the realised savings by approximately £10m. The full-year FY19 position is still expected to be earnings and cashflow neutral.

 

Disposal

On 15 November 2018, Kier agreed the terms of the disposal of its interest in KHSA Limited to Downer Group, the joint venture partner, for a total cash consideration of up to AUS$43.7m (c.£24m). The proceeds will service the reduction of the Group's net debt.

 

Financial position

The Group continues to focus on operational cash generation and net debt reduction, anticipating average monthly net debt of approximately £390m for the first half of FY19, compared with approximately £410m for the second half of FY18. The level of net debt is increasingly a key focus for stakeholders in the industry and the Board recognises the importance of a strong balance sheet to take advantage of opportunities to underpin its future performance.

 

Outlook

The FPK programme positions the Group well for an improvement in profitability and cash generation, and its order books and development pipelines remain strong.

 

- ENDS -

For further information, please contact:

 

Richard Mountain/Nick Hasell, FTI Consulting +44 (0)203 727 1340

 

Cautionary statement

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFKPDPCBDDADD
Date   Source Headline
17th Apr 202412:30 pmRNSDirector/PDMR Shareholding
8th Apr 202411:26 amRNSDirector/PDMR Shareholding
5th Apr 202410:15 amRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:00 pmRNSTotal Voting Rights
20th Mar 20245:48 pmRNSDirector/PDMR Shareholding
19th Mar 202410:12 amRNSDirector/PDMR Shareholding
15th Mar 20248:40 amRNSPost Stabilisation Notice
11th Mar 202410:37 amRNSBlock Listing Application
7th Mar 20247:00 amRNSResults for the period ended 31 December 2023
1st Mar 202410:11 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSGreen Economy Mark and SBTi certifications
20th Feb 20241:43 pmRNSDirector/PDMR Shareholding
15th Feb 202411:05 amRNSKier Group plc successfully issues Senior Notes
15th Feb 202410:09 amRNSHolding(s) in Company
8th Feb 20245:22 pmRNSKier Group plc Announces Pricing of Senior Notes
6th Feb 202410:59 amRNSPre Stabilisation Notice
5th Feb 20248:03 amRNSKier Announces Proposed Offer of Senior Notes
1st Feb 20242:16 pmRNSTotal Voting Rights
22nd Jan 202410:30 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
5th Jan 202411:47 amRNSHolding(s) in Company
2nd Jan 20243:44 pmRNSBlock listing Interim Review
2nd Jan 20243:42 pmRNSTotal Voting Rights
27th Dec 202310:10 amRNSReduction of Capital
27th Dec 202310:05 amRNSHolding(s) in Company
27th Dec 202310:02 amRNSHolding(s) in Company
21st Dec 202312:21 pmRNSDirector/PDMR Shareholding
19th Dec 20233:57 pmRNSDirector/PDMR Shareholding
18th Dec 20234:50 pmRNSDirector/PDMR Shareholding
14th Dec 202310:35 amRNSDirectorate Change
1st Dec 202310:53 amRNSTotal Voting Rights
22nd Nov 202311:09 amRNSDirector/PDMR Shareholding
20th Nov 20233:10 pmRNSDirector/PDMR Shareholding
16th Nov 20234:00 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
1st Nov 202312:28 pmRNSTotal Voting Rights
1st Nov 202312:24 pmRNSDirector/PDMR Shareholding
30th Oct 20234:00 pmRNSDirector/PDMR Shareholding
24th Oct 20239:37 amRNSHolding(s) in Company
20th Oct 202312:00 pmRNSDirector/PDMR Shareholding
10th Oct 202310:09 amRNSHolding(s) in Company
6th Oct 20232:34 pmRNSAnnual Financial Report
2nd Oct 202311:15 amRNSTotal Voting Rights
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202310:09 amRNSHolding(s) in Company
20th Sep 20231:42 pmRNSHolding(s) in Company
20th Sep 20231:39 pmRNSDirector/PDMR Shareholding
15th Sep 20234:06 pmRNSDirector/PDMR Shareholding
14th Sep 20232:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.